Skip to main content
. 2018 Sep 6;2018:9432606. doi: 10.1155/2018/9432606

Table 3.

Pathologic results after repeat TURBT in patients.

Non-referred group T stage after re-TURBT (%)

Initial T N T0 Ta T1 T2 CIS

Ta 33 14 (42.4%) 11 (33.3%) 3 (9.1%) 1 (3.0%) 4 (12.1%)

T1 187 83 (44.4%) 40 (21.4%) 41 (21.9%) 6 (3.2%) 17 (9.1%)

Referred group

Initial T N T0 Ta T1 T2 CIS

Ta 15 5 (33.3%) 4 (26.7%) 4 (26.7%) 0 (0%) 2 (13.3%)

T1 54 7 (13.0%) 4 (7.4%) 24 (44.4%) 11 (20.4%) 8 (14.8%)

TURBT: transurethral resection of bladder tumor.